EU to Weigh New Safety Data on Biogen, Eisai Alzheimer’s Drug
European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...
Seeking Alpha on MSN5h
Biogen, Eisai Alzheimer’s drug review delayed in EU
Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.
Ozempic May Protect Against Alzheimer’s
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
Hosted on MSN5h
What if this simple anesthetic gas could cure Alzheimer's? 🧠
What if a gas used in anesthesia became a weapon against Alzheimer's disease? A recent study reveals that xenon, a noble gas, ...
BMJ14h
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment
Outcome measures were Alzheimer type dementia or cognitive decline at follow up. Delayed recall was tested with a verbal learning test. Results: Ten patients had experienced cognitive decline at ...